Aster DM Healthcare Limited (BOM:540975)
India · Delayed Price · Currency is INR | Market Cap | 418.31B +46.3% |
| Revenue (ttm) | 46.43B +12.2% |
| Net Income | 3.88B -92.8% |
| EPS | 7.52 -93.0% |
| Shares Out | n/a |
| PE Ratio | 107.77 |
| Forward PE | 34.35 |
| Dividend | 4.00 (0.49%) |
| Ex-Dividend Date | Apr 2, 2026 |
| Volume | 38,357 |
| Open | 795.65 |
| Previous Close | 788.05 |
| Day's Range | 787.00 - 818.45 |
| 52-Week Range | 519.80 - 847.95 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 795.27 (-1.7%) |
| Earnings Date | Jul 30, 2026 |
About Aster DM Healthcare
Aster DM Healthcare Limited, together with its subsidiaries, provides healthcare services in India. It operates through Hospitals, Clinics, Wholesale Pharmacies, and Others segments. The company operates hospitals, clinic, and in-house pharmacies at the hospitals and clinics. It also offers healthcare consultancy and other services. In addition, the company operates retail pharmacies and optical outlets. Aster DM Healthcare Limited was founded in 1987 and is based in Bengaluru, India. [Read more]
Financial Performance
In fiscal year 2026, Aster DM Healthcare's revenue was 46.43 billion, an increase of 12.20% compared to the previous year's 41.38 billion. Earnings were 3.88 billion, a decrease of -92.78%.
Financial StatementsAnalyst Summary
According to 11 analysts, the average rating for 540975 stock is "Buy." The 12-month stock price target is ₹795.27, which is a decrease of -1.70% from the latest price.
News
Aster DM Healthcare receives NCLT approval for amalgamation with Quality Care India
Aster DM Healthcare has received approval from the National Company Law Tribunal (NCLT), Hyderabad Bench, for its Scheme of Amalgamation with Quality Care India Limited (QCIL). The tribunal sanctioned...
Aster DM Healthcare acquires equity shares worth Rs 45.08 crore in Sarjapur entity
Aster DM Healthcare has acquired 4,50,89,995 equity shares in its subsidiary, Aster DM Super-Specialty Hospital (Sarjapur) Private Limited, through a rights issue. The acquisition, valued at ₹45,08,99...
Aster DM subsidiary allots 21,40,000 Series A CCPS and 18,40,000 Series B CCPS
Aster DM Healthcare's subsidiary, Aster DM Multispecialty Hospital Private Limited (ADMPL), has announced the allotment of 21,40,000 fully paid-up Series A Compulsorily Convertible Preference Shares (...
Aster DM Healthcare Slides: Investor presentation
Aster DM Healthcare has posted slides in relation to its latest quarterly earnings report, which was published on June 3, 2026.
Aster DM Healthcare shares surge over 10% after strong Q4 Results; Net profit jumps 80.4% YoY
Shares of Aster DM Healthcare rallied more than 10% in early trade on Monday after the company reported a strong set of earnings for the fourth quarter of FY26, driven…
Aster DM Healthcare Transcript: Q4 25/26
The group delivered strong double-digit revenue and EBITDA growth in Q4 and FY 2026, driven by higher patient volumes, improved case mix, and disciplined expansion. The merger with Quality Care is on track, with significant capacity additions and margin expansion expected post-merger.
Aster DM Healthcare Quarterly report: Q4 2026
Aster DM Healthcare has published its Q4 2026 quarterly earnings report on May 1, 2026.
Aster DM Healthcare Slides: Q4 2026
Aster DM Healthcare has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 1, 2026.
Stocks to buy: What's the outlook for Nifty for April 27-April 30 week? Check list of top stock recommendations
Stock market recommendations: Aster DM Healthcare, and GE Vernova T&D India have been picked by Sudeep Shah, Head - Technical Research and Derivatives, SBI Securities as the top stocks to buy this wee...
Stocks to buy: What's the outlook for Nifty for March 30-April 3 week? Check list of top stock recommendations
Stock market recommendations: Aster DM Healthcare, and Karur Vysya Bank are the top stocks that have been recommended by Sudeep Shah, Head - Technical Research and Derivatives, SBI Securities for the ...
Aster DM Healthcare announces Rs 3 interim dividend per share for FY 2025-26
Aster DM Healthcare has declared an interim dividend of ₹3 per equity share for the financial year 2025-26. The announcement was made during the Board of Directors meeting held on…
Aster DM Healthcare secures 96.68% shareholder approval for merger with QCIL
Aster DM Healthcare Limited has received an overwhelming 96.68% voting approval from its shareholders for the proposed merger with Quality Care India Limited (QCIL). The merger is set to create…
Aster DM Healthcare secures 100% approval for amalgamation scheme from creditors
Aster DM Healthcare's unsecured trade creditors have overwhelmingly approved the Scheme of Amalgamation with Quality Care India Limited. The resolution received 100% votes in favour from the creditors...
Aster DM Healthcare appoints Dr. Azad Moopen as Executive Director
Aster DM Healthcare has announced the appointment of Dr. Azad Moopen as Executive Director, effective from 15 April 2026 to 28 May 2028. This decision was made during the company's…
Pharma sector stocks today, Feb 11: Aster DM Healthcare up 2.39%, Jeena Sikho down 2.75%, Concord Biotech falls 2.10%
The Indian pharmaceutical sector showed mixed performance on February 11, 2026, as of around 10:20 AM IST. The Nifty Pharma...
Aster DM Healthcare Transcript: Q3 25/26
Combined Aster and Quality Care delivered strong double-digit revenue and EBITDA growth, with robust performance in Kerala and significant expansion plans underway. Margin pressures from new capacity and talent investments are expected to be offset by synergies post-merger, targeting 24%-25% EBITDA margins in three years.
Aster DM Healthcare Quarterly report: Q3 2026
Aster DM Healthcare has published its Q3 2026 quarterly earnings report on February 2, 2026.
Aster DM Healthcare Slides: Q3 2026
Aster DM Healthcare has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on February 2, 2026.
Aster DM Healthcare Transcript: Q2 25/26
Q2 FY 2026 saw robust revenue and margin growth, led by Kerala's recovery and strong performance across clusters. The merger with QCL is progressing, with significant expansion and synergy plans set to drive future growth and profitability.
Aster DM Healthcare Quarterly report: Q2 2026
Aster DM Healthcare has published its Q2 2026 quarterly earnings report on November 7, 2025.
Aster DM Healthcare Slides: Q2 2026
Aster DM Healthcare has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on November 7, 2025.
Stocks hitting 52-week highs today: Aster DM Healthcare, Ather Energy, and RBL Bank among top movers
Several stocks touched fresh 52-week highs in today’s session, reflecting positive market sentiment across sectors. Aster DM Healthcare, Ather Energy,...
Aster DM Healthcare CEO of Digital Health Dr. Harsha Rajaram resigns
Aster DM Healthcare has announced that Dr. Harsha Rajaram, CEO of Aster Digital Health and a senior management leader at the company, has resigned from his position, effective from the close of busine...
Aster DM Healthcare share price: HSBC maintains buy, sees 6% upside as merger with QCIL progresses
HSBC has reiterated its buy rating on Aster DM Healthcare with a target price of ₹680 per share. At the current market price of ₹641.10, the target implies an upside of about 6 percent. The brokerage ...
Aster DM Healthcare Transcript: Q1 25/26
Q1 FY 2026 delivered 8% revenue and 21% EBITDA growth, with strong recovery in Kerala and robust expansion plans. The QCIL merger is progressing, creating a 10,350+ bed network, while ARPOB and margins continue to improve across clusters.